Longeveron Inc (LGVN)

$1.56 -0.08 (-4.88%)
Market Cap 24.93M
Revenue (ttm) 2.39M
Net Income (ttm) -15.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -668.20%
Debt to Equity Ratio 0.00
Volume 185,048
Avg Vol 412,022
Day's Range N/A - N/A
Shares Out 14.93M
Stochastic %K 57%
Beta 0.21
Analysts Strong Sell
Price Target $8.89

Company Profile

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to...

Industry: Biotechnology
Sector: Healthcare
Phone: 844 470 2550
Address:
Life Science & Technology Park, Suite 520 1951 NW 7th Avenue, Miami, United States
Dorps332
Dorps332 Jul. 29 at 11:35 AM
$LGVN a great way for Rock Soffer to honor his father and the co-founder of this company is to see this company out to the end. Do a fund raise by allowing Rock Soffer to fund the end of the trials and get the product to market!
0 · Reply
kadeee
kadeee Jul. 28 at 9:08 PM
$MIRA Let me in on the fun! $AIM $LGVN $VAPE
0 · Reply
BrokeSystem
BrokeSystem Jul. 28 at 3:38 AM
$LGVN let her rip!
0 · Reply
Dorps332
Dorps332 Jul. 26 at 12:25 AM
$LGVN 😢
0 · Reply
HoldingontoPennies
HoldingontoPennies Jul. 25 at 2:03 PM
$LGVN 🥱
0 · Reply
terrapin22
terrapin22 Jul. 24 at 8:28 PM
$LGVN a little volume goes a long way with this thang. Patience will pay
0 · Reply
MaryRodas788
MaryRodas788 Jul. 24 at 4:57 PM
$LGVN is hyped for regenerative focus, but RMTG is delivering. Their new Puerto Rico partner will serve as both a clinic and training center—huge regional step.
0 · Reply
Dorps332
Dorps332 Jul. 24 at 9:19 AM
$LGVN
0 · Reply
Dorps332
Dorps332 Jul. 23 at 8:12 PM
$LGVN come on management. Give us an announcement so we can be like $ABVX
1 · Reply
smoothest06
smoothest06 Jul. 23 at 3:30 PM
$LGVN
0 · Reply
Latest News on LGVN
Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease

Jul 21, 2025, 9:15 AM EDT - 8 days ago

Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)

Jul 8, 2025, 9:15 AM EDT - 21 days ago

Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM)

Longeveron® Appoints Than Powell as Chief Business Officer

Jun 26, 2025, 9:05 AM EDT - 4 weeks ago

Longeveron® Appoints Than Powell as Chief Business Officer

Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Jun 24, 2025, 6:30 AM EDT - 5 weeks ago

Longeveron® Announces Completion of Enrollment of Pivotal Phase 2b Clinical Trial Evaluating Laromestrocel as a Treatment for Hypoplastic Left Heart Syndrome (HLHS)

Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Jun 9, 2025, 9:15 AM EDT - 7 weeks ago

Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference

Longeveron® to Attend BIO International Convention 2025

May 20, 2025, 9:15 AM EDT - 2 months ago

Longeveron® to Attend BIO International Convention 2025

Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient

May 12, 2025, 7:15 AM EDT - 2 months ago

Longeveron® Named XPRIZE Healthspan Semifinalist and Top 40 Milestone 1 Award Recipient

Longeveron Inc. (LGVN) Q1 2025 Earnings Call Transcript

May 9, 2025, 5:31 PM EDT - 2 months ago

Longeveron Inc. (LGVN) Q1 2025 Earnings Call Transcript

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

May 8, 2025, 4:05 PM EDT - 2 months ago

Longeveron® Announces First Quarter 2025 Financial Results and Provides Business Update

Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

May 2, 2025, 8:30 AM EDT - 3 months ago

Longeveron® to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025

Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease

Mar 11, 2025, 8:30 AM EDT - 5 months ago

Longeveron® Announces Nature Medicine Publication of Results of Phase 2a Clinical Trial Evaluating Laromestrocel (Lomecel-B™) in Alzheimer's Disease

Longeveron® to Present at the 37th Annual Roth Conference

Mar 5, 2025, 9:25 AM EST - 5 months ago

Longeveron® to Present at the 37th Annual Roth Conference

Longeveron Inc. (LGVN) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 7:04 PM EST - 5 months ago

Longeveron Inc. (LGVN) Q4 2024 Earnings Call Transcript

Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update

Feb 28, 2025, 4:04 PM EST - 5 months ago

Longeveron® Announces Full-Year 2024 Financial Results and Provides Business Update

Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

Feb 18, 2025, 9:25 AM EST - 5 months ago

Longeveron® Announces World Health Organization Approval of “laromestrocel” as International Non-proprietary Name for Stem Cell Therapy Lomecel-B™

Longeveron to Present at Biotech Showcase 2025

Dec 18, 2024, 9:10 AM EST - 7 months ago

Longeveron to Present at Biotech Showcase 2025

Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024

Dec 2, 2024, 9:05 AM EST - 8 months ago

Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024

Longeveron, Inc. (LGVN) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:37 PM EST - 9 months ago

Longeveron, Inc. (LGVN) Q3 2024 Earnings Call Transcript

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)

Nov 11, 2024, 9:05 AM EST - 9 months ago

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC)

Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Nov 4, 2024, 4:05 PM EST - 9 months ago

Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)

Oct 29, 2024, 10:00 AM EDT - 9 months ago

Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)

Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting

Oct 27, 2024, 3:10 PM EDT - 9 months ago

Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting

Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)

Oct 14, 2024, 9:05 AM EDT - 10 months ago

Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24)

Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting

Oct 9, 2024, 9:05 AM EDT - 10 months ago

Longeveron® Lomecel-B™ 5-Year Long-term Transplant-free Survival Data in HLHS Selected for Oral Presentation at the Congenital Heart Surgeons' Society (CHSS) 51st Annual Meeting

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day

Oct 7, 2024, 9:05 AM EDT - 10 months ago

Longeveron® to Present at the UBS Virtual Organ Restoration and Cell Therapy Day

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Oct 2, 2024, 9:05 AM EDT - 10 months ago

Longeveron® to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference

Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa

Sep 26, 2024, 9:05 AM EDT - 10 months ago

Longeveron to Attend Alliance for Regenerative Medicine's Cell & Gene Meeting on the Mesa

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 26, 2024, 4:05 PM EDT - 1 year ago

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Longeveron, Inc. (LGVN) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:58 PM EDT - 1 year ago

Longeveron, Inc. (LGVN) Q2 2024 Earnings Call Transcript

Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer's Disease at the Alzheimer's Association International Conference® (AAIC)

Jul 28, 2024, 4:51 PM EDT - 1 year ago

Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer's Disease at the Alzheimer's Association International Conference® (AAIC)

Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 19, 2024, 4:05 PM EDT - 1 year ago

Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jul 18, 2024, 8:45 AM EDT - 1 year ago

Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Longeveron stock opened 100% up on Wednesday: explore why

Jul 10, 2024, 11:38 AM EDT - 1 year ago

Longeveron stock opened 100% up on Wednesday: explore why

Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer's Disease

Jul 10, 2024, 7:30 AM EDT - 1 year ago

Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer's Disease

Neha Motwani Elected to Longeveron® Board of Directors

Jul 9, 2024, 9:00 AM EDT - 1 year ago

Neha Motwani Elected to Longeveron® Board of Directors

Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors

Jul 8, 2024, 9:00 AM EDT - 1 year ago

Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors

Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction

Jun 18, 2024, 4:48 PM EDT - 1 year ago

Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction

Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024

Jun 17, 2024, 9:00 AM EDT - 1 year ago

Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024

Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds

Jun 17, 2024, 8:38 AM EDT - 1 year ago

Longeveron Announces Exercise of Warrants for $4.4 Million Gross Proceeds

Why has Longeveron stock tripled in two days?

Jun 13, 2024, 9:45 AM EDT - 1 year ago

Why has Longeveron stock tripled in two days?

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Jun 3, 2024, 9:00 AM EDT - 1 year ago

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Longeveron® to Attend BIO International Convention 2024

May 28, 2024, 8:05 AM EDT - 1 year ago

Longeveron® to Attend BIO International Convention 2024

Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript

May 17, 2024, 11:08 PM EDT - 1 year ago

Longeveron Inc. (LGVN) Q1 2024 Earnings Call Transcript

Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update

May 14, 2024, 4:05 PM EDT - 1 year ago

Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update

Longeveron Announces Board of Directors Planned Transitions

May 10, 2024, 4:05 PM EDT - 1 year ago

Longeveron Announces Board of Directors Planned Transitions

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

May 2, 2024, 8:03 AM EDT - 1 year ago

Longeveron to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Longeveron to Present at the Planet MicroCap Showcase

Apr 25, 2024, 4:05 PM EDT - 1 year ago

Longeveron to Present at the Planet MicroCap Showcase

Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering

Apr 18, 2024, 4:05 PM EDT - 1 year ago

Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering

Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds

Apr 17, 2024, 8:00 AM EDT - 1 year ago

Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds

Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)

Apr 15, 2024, 8:30 AM EDT - 1 year ago

Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B™ in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)

Dorps332
Dorps332 Jul. 29 at 11:35 AM
$LGVN a great way for Rock Soffer to honor his father and the co-founder of this company is to see this company out to the end. Do a fund raise by allowing Rock Soffer to fund the end of the trials and get the product to market!
0 · Reply
kadeee
kadeee Jul. 28 at 9:08 PM
$MIRA Let me in on the fun! $AIM $LGVN $VAPE
0 · Reply
BrokeSystem
BrokeSystem Jul. 28 at 3:38 AM
$LGVN let her rip!
0 · Reply
Dorps332
Dorps332 Jul. 26 at 12:25 AM
$LGVN 😢
0 · Reply
HoldingontoPennies
HoldingontoPennies Jul. 25 at 2:03 PM
$LGVN 🥱
0 · Reply
terrapin22
terrapin22 Jul. 24 at 8:28 PM
$LGVN a little volume goes a long way with this thang. Patience will pay
0 · Reply
MaryRodas788
MaryRodas788 Jul. 24 at 4:57 PM
$LGVN is hyped for regenerative focus, but RMTG is delivering. Their new Puerto Rico partner will serve as both a clinic and training center—huge regional step.
0 · Reply
Dorps332
Dorps332 Jul. 24 at 9:19 AM
$LGVN
0 · Reply
Dorps332
Dorps332 Jul. 23 at 8:12 PM
$LGVN come on management. Give us an announcement so we can be like $ABVX
1 · Reply
smoothest06
smoothest06 Jul. 23 at 3:30 PM
$LGVN
0 · Reply
Ostocks339
Ostocks339 Jul. 23 at 2:53 PM
$IOVA $OCGN $LGVN This sector is ON FIRE!
0 · Reply
H65
H65 Jul. 23 at 2:17 PM
$LGVN Up! Up! Up! Plz.
0 · Reply
Ostocks339
Ostocks339 Jul. 23 at 1:24 PM
$OCGN $LGVN $IOVA All about to explode soon.
0 · Reply
Ueberschlaefer
Ueberschlaefer Jul. 22 at 11:48 PM
$LGVN former long on LGVN. i shorted this again yesterday. didn't win much, but it only took a few seconds. so many bears rip this thing apart whenever it pops its head up. if you are a new bagholder, you'll be here a while. welcome!
3 · Reply
TuJaro
TuJaro Jul. 22 at 7:13 PM
$LGVN can someone explain it to me in easy language what is "short shares availability" are they different from regular shares? I'm new to trading, thanks.
2 · Reply
smoothest06
smoothest06 Jul. 22 at 5:06 PM
$LGVN 🤑🤑
0 · Reply
smoothest06
smoothest06 Jul. 22 at 4:34 PM
$LGVN
0 · Reply
BobAxe
BobAxe Jul. 22 at 1:59 PM
$LGVN yes adding around here
0 · Reply
FonsieTrader
FonsieTrader Jul. 22 at 9:13 AM
$LGVN found this beauty chart ready to blow up! Low floater, this one ready for a big breakout! Stay tuned on it
0 · Reply
smoothest06
smoothest06 Jul. 22 at 8:03 AM
$LGVN
0 · Reply
Bluesclues692
Bluesclues692 Jul. 22 at 6:44 AM
$SPCE will buy with $OPEN and $LGVN profits
0 · Reply
smoothest06
smoothest06 Jul. 21 at 9:14 PM
$LGVN
1 · Reply